GHTM

Global Health and Tropical Medicine

  • GHTM
    • About GHTM
    • Governance
    • Impact
    • Members
    • Scientific Advisory Board
    • Reports
      • GHTM
      • Scientific Advisory Board
  • Research
    • Cross-cutting issues
      • Global Pathogen Dispersion and Population Mobility
      • Drug Discovery and Drug Resistance
      • Diagnostics
      • Public Health Information
      • Fair Research Partnerships
    • Research Groups
      • PPS – Population health, policies and services
      • THOP – TB, HIV and opportunistic diseases and pathogens
      • VBD – Vector borne diseases
      • IHC – Individual health care
    • Research in numbers
      • 2023
      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
    • Projects
      • Ongoing Projects
      • Completed Projects
  • Outreach
    • Events
    • News
    • Policy Support & Community Outreach
  • Publications
    • 2024
    • 2023
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
  • Capacity Building
    • Education
      • Master Theses
      • PhD Theses
    • International
  • Infrastructures
  • Networks & Partnerships
Home / Events / GHTM Sessions | Monitoring the efficacy of benzimidazoles and emerging resistance to geohelminths in schoolchildren in Cuba

GHTM Sessions | Monitoring the efficacy of benzimidazoles and emerging resistance to geohelminths in schoolchildren in Cuba

February 2, 2026

📅 Date: 18 February 2026
🕒 Time: 11:30-13:30
📍 Location: ZOOM & SALA FRAGA DE AZEVEDO

Geohelminth infections, mainly caused by Ascaris lumbricoides, Trichuris trichiura, Ancylostoma duodenale, and Necator americanus, remain a significant public health problem in Latin America and the Caribbean, particularly among children. Although Cuba reports one of the lowest national prevalence rates in the region, recent surveys conducted between 2023 and 2024 have identified local hotspots with high prevalence, highlighting persistent inequalities in sanitation and living conditions.

The control of these infections relies largely on preventive chemotherapy using benzimidazole drugs, such as albendazole and mebendazole. However, the prolonged use of these medicines raises concerns about the potential emergence of anthelmintic resistance, a phenomenon already well documented in veterinary medicine. As both drugs share the same mechanism of action, resistance could seriously compromise the effectiveness of current control strategies.

The World Health Organization recommends monitoring therapeutic efficacy through egg reduction rates using coprological methods, including the Kato-Katz technique, complemented by molecular approaches to detect β‑tubulin gene mutations associated with resistance.

During the upcoming session, a proposed study involving Cuban children aged 5 to 14 years will be presented, focusing on evaluating the efficacy of albendazole and mebendazole through both parasitological and molecular indicators. This integrated approach aims to lay the groundwork for systematic surveillance of human anthelmintic resistance in Cuba, contributing to more effective and sustainable control measures.

This GHTM Session highlights the work carried out under the IHMT NOVA / Casa da América Latina / Millennium bcp Foundation Chair, awarded to Prof. Lazara Rojas Rivera (IPK, Cuba), further strengthening the collaboration between IHM NOVA and Instituto de Medicina Tropical Pedro Kourí (IPK).

About Rojas Rivera Lazara

Lázara Rojas Rivera is a medical microbiologist with a PhD and a Master’s in Infectious Diseases of Parasitic Etiology. She is a Senior Researcher and Full Professor at Instituto de Medicina Tropical Pedro Kourí (IPK) in Havana, Cuba, where she has worked since 1983. Since 1987, she has directed the National Malaria Reference Laboratory and served as Head of the Parasitology Department and Deputy Director for Medical Parasitology Research. She has acted as a consultant for the Pan American Health Organization (PAHO) and World Health Organization (WHO) in Latin America, Africa, and the Caribbean. Dr. Rojas Rivera has participated in over 30 international scientific meetings, supervised specialists and graduate students, authored numerous publications, and developed key research lines in medical parasitology. Her work has been recognized by Cuba’s Ministry of Public Health and the Academy of Sciences.

About Prof. Rojas Rivera Lazara
  • Academic Background: Medical Microbiologist, Master’s and PhD in Infectious Diseases of Parasitic Etiology. Extensive academic training in parasitology and tropical medicine

  • Career Path: Senior Researcher and Full Professor at IPK, Havana, Cuba, since 1983, Director of the National Malaria Reference Laboratory since 1987. Head of the Parasitology Department (since 1996) and Deputy Director for Medical Parasitology Research (since 1997). Temporary consultant for the PAHO and the WHO in countries across Latin America, Africa, and the Caribbean. Participant in over 30 international scientific meetings; member of academic juries; supervisor of specialists, master’s, and PhD students.

  • Research Focus: Medical parasitology, with emphasis on malaria and other parasitic diseases.nd synthetic compounds with leishmanicidal activity; Development of four key research lines in parasitology.

  • Prizes/Awards: Recognized by Cuba’s Ministry of Public Health and the Academy of Sciences for outstanding scientific contribution.

  • Profiles & Publications:
    • ResearchGate
    • Google Scholar

If you are a GHTM member, you will receive the details of the session by e-mail. If you are not a GHTM member and would like to join the session, please contact us at ghtm-info@ihmt.unl.pt.

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on Pinterest (Opens in new window) Pinterest
  • Click to share on WhatsApp (Opens in new window) WhatsApp
  • Click to print (Opens in new window) Print

About GHTM

GHTM is a R&D Unit that brings together researchers with a track record in Tropical Medicine and International & Global Health. It aims at strengthening Portugal's role as a leading partner in the development and implementation of a global health research agenda. Our evidence-based interventions contribute to the promotion of equity in health and to improve the health of populations.

Contacts

Rua da Junqueira, 100
1349-008 Lisboa
Portugal

+351 213 652 600

  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Map

  • Events
  • Research Groups
  • Cross-cutting issues
© Copyright 2026 IHMT-UNL All Rights Reserved.
  • Universidade Nova de Lisboa
  • Fundação para a Ciência e a Tecnologia

    UIDB/04413/2020
    UIDP/04413/2020

 

Loading Comments...
 

    We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.